Moderna Inc (MRNA)

Exchange
NASDAQ
Symbol
MRNA
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    52.61
  • High
    52.86
  • Low
    49.60
  • Close
    51.81
  • Volume
    10,681,500

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
35.39
Receivables turnover
6.63
Payables turnover
13.75
Working capital turnover
0.92
Days of inventory on hand (DOH)
10.31
Days of sales outstanding (DSO)
55.09
Number of days of payables
26.55
Fixed asset turnover
4.48
Total asset turnover
0.37
 Liquidity ratios
Current ratio
3.42
Quick ratio
3.19
Cash ratio
2.85
Cash conversion cycle
38.85
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.33
Interest coverage
—
 Profitability ratios
Gross profit margin
-5.77%
Operating profit margin
-62.73%
Pretax margin
-58.33%
Net profit margin
-69.75%
Operating return on assets (Operating ROA)
-23.01%
Return on assets (ROA)
-25.58%
Return on total capital
-30.60%
Return on equity (ROE)
-34.03%